Content area
Abstract
MDS Inc. senior management and Board members have been active in an oversight role in the development of the review plan. In addition, MDS Inc. had retained Lachman Consultant Services Inc., a highly knowledgeable and respected advisor, to provide independent advice to the MDS Inc. Board and to assist in the review plan development. Lachman will also be involved in overseeing the execution of the review plan by MDS Pharma Services.
MDS Pharma Services is an integral part of MDS Inc. (TSX:MDS)(NYSE:MDZ). MDS Inc. has more than 9,000 highly skilled people in 25 countries providing a diverse range of superior products and services to increase our customers' speed, precision and productivity in the drug development and disease diagnosis processes. We are a global health and life sciences company, recognized for our reliability and collaborative relationships. Please refer to our website at www.mdsintl.com to find out more about how we help create better outcomes in the treatment of disease.